Imagine a World without Cancer The ASCEND Foundation Home
Home About Us Prevention News Join Us Community Contact Us
.. Mission
.. Annie's Story
.. Board of Directors
.. Advisory Board
.. Finances
.. ASCEND News



Losing the War on Cancer

For years, the National Cancer Institute (NCI) has asserted that cancer incidence in the US is on the decline. But a recent scientific study undercuts this claim. It turns out that various flaws and delays in the way the data were reported to the US government created a false impression that progress was being made. In fact, American cancer rates have been rising, not falling, for the most common kinds of cancer.

The reversal of the NCI's erroneous statistics does not come from the medical fringe. It appears in a recent issue of the Journal of the National Cancer Institute (JNCI) itself, written by scientists at the NCI's own Biometry Research Group. It is a reversal with important political implications for the struggling "war on cancer."

The Right Track?
In December 1971, President Nixon launched America's "war on cancer," putting billions of dollars of resources behind a fight to control this dread disease. One obvious measure of progress has been the rate at which cancer afflicts the general population. If the incidence of cancer is rising, then something is obviously wrong with the strategy. If it goes down, however, it implies that effective measures are being implemented for cancer prevention.

In December 1971, President Nixon launched America's "war on cancer," putting billions of dollars of resources behind a fight to control this dread disease. One obvious measure of progress has been the rate at which cancer afflicts the general population. If the incidence of cancer is rising, then something is obviously wrong with the strategy. If it goes down, however, it implies that effective measures are being implemented for cancer prevention.

For years the public has been in a peculiar situation. On the one hand, most people with whom I speak express the conviction that cancer is increasing in frequency among their friends, families and neighbors. On the other hand, almost all medical authorities have reassured us that cancer incidence is in fact declining.

In March 1998, the NCI, American Cancer Society (ACS), and Centers for Disease Control and Prevention (CDC) united to issue an unprecedented joint statement, the so-called "Cancer Report Card." This stated:

"Cancer incidence and death rates for all cancers combined and for most of the top 10 cancer sites declined between 1990 and 1995, reversing an almost 20-year trend of increasing cancer cases and deaths in the United States."

The directors of the three agencies exulted in the seeming progress. "These numbers are the best proof that we're on the right track," said Richard Klausner, MD, then the director of the NCI.

"We must seize the opportunity to build, and build significantly, on this trend," added John R. Seffrin, PhD, chief executive officer of the American Cancer Society.

The implications of these findings were vast. The downturn in cancer incidence was taken as a complete vindication of the government's approach, and, by some, as a refutation of the claims of alternative medicine. After all, if the conventional approach was working, some argued, who needs alternatives?

Elizabeth Whelan, ScD, MPH, a frequent critic of alternative medicine, wrote along these lines in an article on the Quackwatch website. In her words: "The false claim that cancer rates are rising is a favorite of quackery promoters who want to undermine public trust in food companies, drug companies, chemical manufacturers, and the medical profession." Naturally, she drew on the 1998 "Cancer Report Card" as proof that "the incidence and overall death rates from cancer have been declining in the United States."

Not Winning the War
Yet according to an excellent recent article by Sharon Begley of the Wall Street Journal, "America isn't winning the war on cancer after all. Contrary to optimistic reports from the National Cancer Institute showing the incidence of several devastating cancers has leveled off or even declined in recent years, rates for at least some of those cancers have been rising, according to a new analysis by NCI scientists."

Begley added, "More accurate information about cancer rates presents a grimmer picture." She called the revised NCI estimates "a dispiriting picture of the nation's progress in preventing cancer."

Cancer on the Rise
In their reanalysis, the authors of the NCI study reviewed delays and errors in reporting for five common types of cancer. They found that rates of breast cancer among white women, which we were told had remained stable since 1987, actually have been rising by a substantial 0.6 percent per year. The NCI scientists called for more research "to explain the cause for the recent rise in breast cancer incidence."

Lung cancer incidence in women was also purported to be flat, but in actuality it too has been rising, by 1.2 percent a year, since 1996. Melanoma rates in white men were said to be steady or even falling. But now we learn that they have been increasing by a formidable 4.1 percent a year since 1981. Similarly, prostate cancer rates in white men, rather than falling, as we were previously assured, have also been rising by 2.2 percent a year.

"For white men, 1998 prostate cancer rates are actually 12 percent higher than originally reported," wrote Begley, while "for black men they are 14 percent higher." The rate of colon and rectal cancer in white women has been rising 2.8 percent annually since 1996, rather than, as originally calculated, less than 1 percent per year.

Muted Response
When the 1998 "Cancer Report Card" was issued, it was publicized throughout the world by a compliant media. Yet in contrast to the universal hoopla that greeted the release of the 1998 findings, the response to this astonishing new study has been muted.

"Maybe we were a little too eager to declare the effectiveness of our intervention and prevention programs," said the NCI's Brenda Edwards. "This tells us something we didn't know about whether our intervention and prevention programs are working," said a spokesperson for the American Cancer Society. True: it tells us that the interventions are not working!

Two weeks after the study was published in JNCI, I can still find no mention of it at cancer.gov, the NCI's website. Nor could I find any mention of this publication at the websites of Reuters, ABC News, the New York Times, or even Google.com, which monitors 4,000 separate news sources. I find it galling that the Pollyanna-like optimism of 1998 was swallowed whole by the media, while the corrective dose of realism has gone unmentioned. Why do I get the feeling that "the powers that be" like it that way?

    Status of CLT Educational Programs

Things continue to develop favorably at the Cytoluminescent Therapy (CLT) program at East Clinic in Ireland. Patients have begun arriving from abroad for treatment there. In two weeks, I will return to Ireland to study recent data on this unique form of light therapy and also to lead educational seminars for international patients. The first two such programs, scheduled for November and December, are already completely booked. I have agreed to lead more such seminars starting in early January 2003. If you are interested in receiving CLT and also in participating in this weeklong educational event with other patients, please contact the clinic directly via email: cancerclt@eircom.net

    Chemotherapy and Supplements

The big debate over whether or not antioxidant supplements conflict with chemotherapy continues. In a recent study, scientists at the National University of Singapore showed that the activity of the common cancer drug Adriamycin (doxorubicin) was affected by supplements of vitamin E or fish oil in an animal population.

Life span and heart damage were recorded in tumor-bearing mice treated with doxorubicin at three different doses and fed a standard diet containing either canola oil, fish oil, canola oil and vitamin E, or fish oil and vitamin E. At a treatment dose of 6.0 or 9.0 milligrams doxorubicin per kilogram, the chemotherapy drug extended life span, and the addition of either fish oil or vitamin E enhanced the drug's beneficial effects. However, an opposite trend was seen when a higher dose of doxorubicin (12.0 milligrams per kilogram) was used. This dose caused severe heart damage in test animals, and the addition of fish oil or vitamin E to the regimen actually aggravated the drug's harmful effects.

Doxorubicin can cause heart damage in human patients as well, but whether fish oil or vitamin E would exacerbate the drug's effects is unknown. Human clinical trials to test the impact of various nutritional supplements on the effectiveness and toxicity of chemotherapy drugs are sorely needed. Such studies would help clear up the many vexing questions associated with these combinations.

    Details on NFAM Award

I mentioned earlier that on November 16, I will be receiving an award from the National Foundation for Alternative Medicine (NFAM). Among the other recipients are Rep. Berkley Bedell; Larry Dossey, MD; Bernie Siegel, MD; and actress Diane Ladd. Details of this award are now available online at http://www.nfam.org/new/november_event_awardees.html
--Ralph W. Moss, Ph.D.

References:
Begley S. New statistics show increase in cancer rates. The Wall Street Journal, October 16, 2002, p. B1.

Clegg LX et al. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-45.

Howe HL et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.

New report on declining cancer incidence and death rates; report shows progress in controlling cancer. [March 12, 1998 joint statement] http://www.nih.gov/news/pr/mar98/nci-12.htm

New report on declining cancer incidence and death rates; report shows progress in controlling cancer. [March 12, 1998 joint statement] http://www.nih.gov/news/pr/mar98/nci-12.htm

Chemotherapy and Supplements
Liu QY and Tan BK. Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice. Lipids 2002;37:549-56.

IMPORTANT DISCLAIMER
The news and other items in this newsletter are intended for informational purposes only. Nothing in this newsletter is intended to be a substitute for professional medical advice.

.. >> Organizational Information

- - Executive Summary
- - Tax Status
- - By Laws
(Downloadable PDF Files)

.. >> See Also
Advisers urge greater mammogram access
Combating Cancer: As costs rise, a focus on prevention
Half of All US Cancer Deaths Preventable: Report
Our Mission OLD
Progress Report in the War on Cancer

Home | About Us | Prevention | News | Join Us | Community | Contact Us
Designed by Ulanji
Website Managed by Just Imagine, Inc.